Mulberry Biotherapeutics
No bio yet
This person is not in any teams
This person is not in any offices
Mulberry Biotherapeutics
Mulberry Biotherapeutics is developing novel targeted bacteria-mediated therapy for patients with NF2 and other non-cancerous neoplasms. The company focused on delivering transformative improvements in the health and quality of life to individuals affected by the rare genetic disorder neurofibromatosis type 2 (NF2).Mulberry Biotherapeutics isbased in Wellesley, MA.